New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Clinical trial NCT06647095 · COMPLETED

Trial details

NCT number: NCT06647095
Sponsor: General University Hospital, Prague
Status: COMPLETED
Study type: OBSERVATIONAL

Healthy Simple Steatosis (SS)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Metabolic Dysfunction-associated Steatohepatitis (MASH)

Start date: 2021-09-01
Primary completion: 2022-09-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.